Ensysce Biosciences Inc. News

Latest updates and market news for ENSC

3 news

Dec 7 - Dec 13, 2025

Page 1

GlobeNewswire

a day ago

Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC)

📈

AI Sentiment

Highly Positive

8/10

ACCESS Newswire

4 days ago

Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid

📈

AI Sentiment

Highly Positive

8/10

Zacks Small Cap Research

4 days ago

ENSC Enrolls First Patient in Critical Phase 3 Trial

📈

AI Sentiment

Highly Positive

9/10

Share this news page

Share on Social Networks: